Literature DB >> 16216987

Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Thomas E Lohmeier1, Terry M Dwyer, Drew A Hildebrandt, Eric D Irwin, Martin A Rossing, David J Serdar, Robert S Kieval.   

Abstract

Despite recent evidence indicating sustained activation of the baroreflex during chronic infusion of angiotensin II (Ang II), sinoaortic denervation does not exacerbate the severity of the hypertension. Therefore, to determine whether Ang II hypertension is relatively resistant to the blood pressure-lowering effects of the baroreflex, the carotid baroreflex was electrically activated bilaterally for 7 days in 5 dogs both in the presence and absence of a continuous infusion of Ang II (5 ng/kg per minute) producing high physiological plasma levels of the peptide. Under control conditions, basal values for mean arterial pressure (MAP) and plasma norepinephrine concentration (NE) were 93+/-1 mm Hg and 99+/-25 pg/mL, respectively. By day 7 of baroreflex activation, MAP and NE were reduced to 72+/-4 mm Hg (-21+/-3 mm Hg) and 56+/-15 pg/mL, respectively, but PRA was unchanged (control=0.41+/-0.06 ng ANG I/mL per hour). All values returned to basal levels by the end of a 7-day recovery period. After 7 days of Ang II infusion, MAP increased from 93+/-3 to 129+/-3 mm Hg, whereas NE fell from 117+/-15 to 86+/-23 pg/mL. During the next 7 days of baroreflex activation/Ang II infusion, further reductions in NE were not statistically significant, and on the final day of baroreflex activation, the reduction in MAP was only 5+/-1 mm Hg, compared with 21+/-3 mm Hg in the control normotensive state. These findings indicate that long-term baroreflex-mediated reductions in arterial pressure are markedly diminished, but not totally eliminated, in the presence of hypertension produced by chronic infusion of Ang II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216987     DOI: 10.1161/01.HYP.0000187011.44201.2e

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  46 in total

Review 1.  Implantable device therapy for the treatment of resistant hypertension.

Authors:  Nikhil Joshi; Jeremy Taylor; John D Bisognano
Journal:  J Cardiovasc Transl Res       Date:  2009-03-04       Impact factor: 4.132

2.  Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Authors:  Thomas E Lohmeier
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

3.  Baroreflex device therapy in the treatment of hypertension.

Authors:  Sarada C Uppuluri; Eugene Storozynsky; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 4.  Vascular endothelial ageing, heartbeat after heartbeat.

Authors:  Eric Thorin; Nathalie Thorin-Trescases
Journal:  Cardiovasc Res       Date:  2009-07-07       Impact factor: 10.787

5.  Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons.

Authors:  Wei Huang; Hui Wang; James J Galligan; Donna H Wang
Journal:  J Hypertens       Date:  2008-10       Impact factor: 4.844

6.  Discharge of RVLM vasomotor neurons is not increased in anesthetized angiotensin II-salt hypertensive rats.

Authors:  Gustavo R Pedrino; Alfredo S Calderon; Mary Ann Andrade; Sergio L Cravo; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-11       Impact factor: 4.733

Review 7.  Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.

Authors:  Kristine Chobanyan-Jürgens; Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

8.  Regulation of renin secretion and arterial pressure during prolonged baroreflex activation: influence of salt intake.

Authors:  Drew A Hildebrandt; Eric D Irwin; Adam W Cates; Thomas E Lohmeier
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

9.  Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 10.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.